Why Large Corporations Are Investing In Marijuana
Since the early 2010s, marijuana has changed from a niche and taboo substance to a serious world-wide commercial business. The large-scale corporation investment in marijuana is perhaps one of the clearest indicators of this shift. Pharmaceutical giants, consumer goods companies and other larger corporations are increasing their investments in marijuana and related cannabis businesses. This trend will help to explain why cannabis is being discussed in board rooms and in public policy forums in the UK.
Changing Social and Regulatory Attitudes on Cannabis
Corporation investment in marijuana is directly associated with changing social attitudes and government regulation of marijuana. Medical marijuana is now recognized as legal in many nations, including the UK, and scientific evidence has helped to eliminate many of the negative stereotypes surrounding cannabis use. As social stigma decreases, corporations view marijuana as a regulated, high-growth market with a long-term growth trajectory.
Predictable Markets
As laws are clarified and markets are developed to provide a structure, large corporations have increased confidence in investing in cannabis related assets, partnerships and research.
Reasons Why Major Corporations Are Investing in Marijuana
There are strategic reasons why major corporations are choosing to invest in marijuana.
Their decisions are based on a combination of market information, consumer behavior and innovation opportunities:
- access to a rapidly expanding global market with long term demand
- development of medical marijuana and pharma applications
- development of non smoking marijuana products (oils, edibles, beverages)
- leveraging current supply chain and branding resources
- establishing a position ahead of pending legislative changes
- for many corporations, marijuana represents a form of diversification, not a source of additional risk.
Pharmaceuticals, Wellness, and Consumer Brands
Pharmaceutical corporations are particularly interested in cannabinoids for pain management, neurology and research into mental health. Well-being and consumer brand corporations are viewing cannabis as a natural evolution of trends towards plant-based and alternative health products. Food and beverage corporations are also tracking cannabis infused products as potential future categories once regulatory frameworks permit.
The UK Perspective
Within the UK, the involvement of corporations in cannabis is currently most visible through the import of medical cannabis, research partnerships and clinic networks as opposed to mass market products. British corporations and investors generally adopt a conservative, compliant strategy, adhering to strict regulatory requirements, while planning for potential market expansion.
Future Implications
The entry of large corporations into the cannabis space indicates that marijuana is no longer perceived as a fad. The infusion of corporate capital provides for a greater level of professionalism, research funding and infrastructure, ultimately shaping the direction of cannabis markets globally.
Follow our marijuana news blog for ongoing coverage of cannabis industry developments, analysis and insight into how marijuana is changing the UK and global economy.